Overview
Multiple epiphyseal dysplasia with severe proximal femoral dysplasia (MED-SPFD) is a rare skeletal disorder characterized by abnormal development of the epiphyses (the growing ends of bones), with particularly pronounced involvement of the proximal femur (the upper part of the thigh bone near the hip joint). This condition belongs to the broader group of multiple epiphyseal dysplasias, which are a family of skeletal dysplasias affecting cartilage and bone development. The disorder primarily affects the musculoskeletal system, leading to significant hip joint abnormalities that may resemble severe Legg-Calvé-Perthes disease or avascular necrosis of the femoral head. Key clinical features include short stature, early-onset hip pain, waddling gait, and progressive joint stiffness. The proximal femoral epiphyses are severely dysplastic, often showing flattening, fragmentation, or irregular ossification on radiographic imaging. Other epiphyses throughout the body may also be affected, though typically less severely than the hips. Patients may develop early-onset osteoarthritis, particularly of the hip joints, which can significantly impair mobility and quality of life. Knee and ankle involvement may also occur, with irregular epiphyseal ossification visible on X-rays. There is currently no cure for this condition. Treatment is primarily supportive and symptomatic, focusing on pain management, physical therapy to maintain joint mobility and muscle strength, and orthopedic interventions as needed. Total hip replacement may become necessary in adolescence or early adulthood due to progressive degenerative changes. Regular orthopedic monitoring is recommended to track disease progression and plan appropriate interventions. Genetic counseling is advised for affected individuals and their families.
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome.
Community
No community posts yet. Be the first to share your experience with Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome.
Start the conversation →Latest news about Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome
No recent news articles for Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome
What is Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome?
Multiple epiphyseal dysplasia with severe proximal femoral dysplasia (MED-SPFD) is a rare skeletal disorder characterized by abnormal development of the epiphyses (the growing ends of bones), with particularly pronounced involvement of the proximal femur (the upper part of the thigh bone near the hip joint). This condition belongs to the broader group of multiple epiphyseal dysplasias, which are a family of skeletal dysplasias affecting cartilage and bone development. The disorder primarily affects the musculoskeletal system, leading to significant hip joint abnormalities that may resemble sev
How is Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome inherited?
Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome typically begin?
Typical onset of Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome is childhood. Age of onset can vary across affected individuals.